发明名称 MODULATION OF RENIN-ANGIOTENSIN SYSTEM (RAS) RELATED DISEASES BY ANGIOTENSINOGEN
摘要 Disclosed herein are antisense compounds and methods for modulating AGT and modulating a RAS pathway related disease, disorder or condition in an individual in need thereof. RAS related diseases in an individual such as hypertension or organ damage can be treated, ameliorated or prevented with the administration of antisense compounds targeted to AGT.
申请公布号 US2015297629(A1) 申请公布日期 2015.10.22
申请号 US201314417762 申请日期 2013.07.26
申请人 Isis Pharmaceuticals, Inc, 发明人 Mullick Adam;Graham Mark J.;Crooke Rosanne M.
分类号 A61K31/7125;A61K9/00;A61K45/06;C12N15/113 主分类号 A61K31/7125
代理机构 代理人
主权项 1. A method for inhibiting AGT expression in an animal having or at risk of having a RAS pathway related disease, disorder and/or condition comprising; (a) selecting the animal suffering from the RAS pathway related disease, disorder or condition, and (b) administering a compound targeting AGT to the animal, wherein the compound administered to the animal inhibits AGT expression in the animal having or at risk of having the RAS pathway related disease, disorder and/or condition.
地址 Carlsbad CA